Tamarind Bio
AI Inference Platform for Drug Discovery
Y CombinatorWinter 2024ActiveB2BAI-powered Drug DiscoveryArtificial IntelligenceSaaSB2B
What they do
Problem
Life science researchers struggle to run computational biology and ML workflows at scale due to complex HPC setup, DevOps overhead, and infrastructure constraints.
Solution
A web and API-based AI inference platform that lets scientists run models like AlphaFold to design and simulate molecules via a simple interface without managing HPC or DevOps.
Who it's for
Researchers and computational biology teams at large pharma companies, biotech firms, and academic institutions.
Founders
Deniz Kavi
Co-founder & CEO
Building great software for life scientists.
Sherry Liu
Founder
I'm currently building Tamarind Bio: easy to use computational biology tools for scientists. I studied Computer Science at Stanford. Previously, I've worked at AWS and as a machine learning researcher at Stanford.
Open roles 6
Company timeline
- Founded2023
- YC batchWinter 2024
- StatusActive
- Team size15 people
- LocationSan Francisco, CA, USA
Similar startups
Numerion Labs
Artificial intelligence for drug discovery.
Inductive Bio
Virtual chemistry labs and AI med chem agents to help drug hunters de…
Reticular
Interpretable AI for drug discovery
Genesis Molecular AI
Foundation models and AI operating system for small molecule drug dis…
b12 Labs
Chemical Copilot for Pharma and Biotech
Olio Labs
Combination therapeutics for the world's toughest diseases